buyWeak cluster of 4
Antonio Grassotti bought $19k of PACK
Managing Director, APAC at Ranpak Holdings Corp.. 7,000 shares at an average of $2.76, traded Nov 2, 2023, filed Nov 6, 2023.
Conviction score
33Value
$19k
7,000 shares
Holdings after
109,130
+7% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleOfficer
- 0Trade size$19k at market
- +3Relative to holdingsHoldings up 7%
- 0Price contextNo price history yet
- +15Cluster4 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0000950103-23-016041, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 2, 2023 | POpen-market purchase Class A common stock | +7,000 | $2.76 | $19k | 109,130 | Nov 6, 2023 |
Related signals
Other insiders at Ranpak Holdings Corp. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 36Weak | Ranpak Holdings Corp. | Mark A. Siebert MD, North America | $1,083 272 shares | - | |
| 41Moderate | Ranpak Holdings Corp. | Alicia M. Tranen director | $16k 5,000 shares | +20% | |
| 30Weak | Ranpak Holdings Corp. | Mark A. Siebert MD, North America | $5,008 1,730 shares | +4% | |
| 44Moderate | Ranpak Holdings Corp. | Alicia M. Tranen director | $38k 12,500 shares | +11% | |
| 43Moderate | Ranpak Holdings Corp. | Eric Laurensse Managing Director, Europe | $54k 19,000 shares | +20% | |
| 41Moderate | PACKbuy Ranpak Holdings Corp. | Alicia M. Tranen director | $389k 132,500 shares | +230% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.